 This study found that older recipients and those who received thymoglobulin were more likely to develop CMV disease after kidney transplantation. Additionally, no association was observed between the immunosuppressive regimen and CMV disease except for thymoglobulin. This article was authored by Viviana Navarro Rodriguez, Alvaro Herrera Muñoz, Adrián Castro, and others.